Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Catherine Derington to Female

This is a "connection" page, showing publications Catherine Derington has written about Female.

 
Connection Strength
  
 
 
0.458
  
  1. Derington CG, Berchie RO, Greene T, Jacobs JA, Moran AE, Xu Y, Narita K, Zheutlin AR, Cohen JB, Shimbo D, Bress AP. Using PREVENT Equations to Compare Intensive vs Standard Systolic Blood Pressure Control for Primary Prevention in SPRINT. J Am Coll Cardiol. 2025 Oct 28; 86(17):1437-1448.
    View in: PubMed
    Score: 0.032
  2. Derington CG, Sarwal A, Wei G, Hartsell SE, Throolin M, Singh R, Nevers MR, Zhang C, Katkam N, Takyi A, Chakravartula AR, Babu P, Deshmukh VG, Boucher RE, Drakos SG, Greene T, Shen J, Beddhu S. Liraglutide vs Semaglutide vs Dulaglutide in Veterans With Type 2 Diabetes. JAMA Netw Open. 2025 10 01; 8(10):e2537297.
    View in: PubMed
    Score: 0.032
  3. Derington CG, Berchie RO, Mohanty AF, Jacobs JA, Xu Y, King JB, Rethy L, Cushman WC, Zickmund SL, Ho PM, Raghavan S, Cohen JB, Bress AP. First-Line ß-Blocker Use for Hypertension in the Veterans Health Administration. JAMA Netw Open. 2025 08 01; 8(8):e2529026.
    View in: PubMed
    Score: 0.032
  4. Derington CG, Berchie RO, Scharfstein DO, Andrews RM, Greene TH, Xu Y, King JB, Supiano MA, Sonnen JA, Williamson J, Pajewski NM, Pruzin JJ, Cohen JB, Bress AP. Effect of Initiation and Continuous Adherence to ARBs Versus ACEIs on Risk of Adjudicated Mild Cognitive Impairment or Dementia. J Gerontol A Biol Sci Med Sci. 2025 06 10; 80(7).
    View in: PubMed
    Score: 0.031
  5. Derington CG, Goodrich GK, Xu S, Clark NP, Reynolds K, An J, Witt DM, Smith DH, O'Keeffe-Rosetti M, Lang DT, Ho PM, Cheetham TC, Comer AC, King JB. Association of Direct Oral Anticoagulation Management Strategies With Clinical Outcomes for Adults With Atrial Fibrillation. JAMA Netw Open. 2023 07 03; 6(7):e2321971.
    View in: PubMed
    Score: 0.027
  6. Derington CG, Bress AP, Herrick JS, Jacobs JA, Zheutlin AR, Berchie RO, Conroy MB, Cushman WC, King JB. Antihypertensive Medication Regimens Used by US Adults With Hypertension and the Potential for Fixed-Dose Combination Products: The National Health and Nutrition Examination Surveys 2015 to 2020. J Am Heart Assoc. 2023 06 06; 12(11):e028573.
    View in: PubMed
    Score: 0.027
  7. Derington CG, Cohen JB, Mohanty AF, Greene TH, Cook J, Ying J, Wei G, Herrick JS, Stevens VW, Jones BE, Wang L, Zheutlin AR, South AM, Hanff TC, Smith SM, Cooper-DeHoff RM, King JB, Alexander GC, Berlowitz DR, Ahmad FS, Penrod MJ, Hess R, Conroy MB, Fang JC, Rubin MA, Beddhu S, Cheung AK, Xian W, Weintraub WS, Bress AP. Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans. PLoS One. 2021; 16(4):e0248080.
    View in: PubMed
    Score: 0.024
  8. Derington CG, Colantonio LD, Herrick JS, Cook J, King JB, Rosenson RS, Poudel B, Monda KL, Navar AM, Mues KE, Stevens VW, Nelson RE, Vanneman ME, Muntner P, Bress AP. Factors Associated With PCSK9 Inhibitor Initiation Among US Veterans. J Am Heart Assoc. 2021 04 20; 10(8):e019254.
    View in: PubMed
    Score: 0.023
  9. Derington CG, King JB, Delate T, Botts SR, Kroehl M, Kao DP, Trinkley KE. Twice-daily versus once-daily lisinopril and losartan for hypertension: Real-world effectiveness and safety. PLoS One. 2020; 15(12):e0243371.
    View in: PubMed
    Score: 0.023
  10. Derington CG, Heath LJ, Kao DP, Delate T. Validation of algorithms to identify elective percutaneous coronary interventions in administrative databases. PLoS One. 2020; 15(4):e0231100.
    View in: PubMed
    Score: 0.022
  11. Derington CG, King JB, Herrick JS, Shimbo D, Kronish IM, Saseen JJ, Muntner P, Moran AE, Bress AP. Trends in Antihypertensive Medication Monotherapy and Combination Use Among US Adults, National Health and Nutrition Examination Survey 2005-2016. Hypertension. 2020 04; 75(4):973-981.
    View in: PubMed
    Score: 0.022
  12. An J, Zhou H, Ni L, Juan R, Portugal C, Romero DI, Reynolds K, Brettler JW, Ong-Su AL, Derington CG, Xu Y, Bress AP, Cohen JB. Trends in Initial Combination Antihypertensive Therapy in a US Health System. Am J Hypertens. 2026 Jun 01; 39(6):787-796.
    View in: PubMed
    Score: 0.008
  13. Jacobs JA, Greene T, Vanneman ME, Kean J, Carter SJ, Shah KS, Pandey A, Derington CG, Zheutlin AR, Fang J, Stehlik J, Fonarow GC, Bress AP. Time to Quadruple Therapy After Initial Diagnosis of Heart Failure With Reduced Ejection Fraction. JAMA Cardiol. 2026 06 01; 11(6):506-514.
    View in: PubMed
    Score: 0.008
  14. Zheutlin AR, Chaitoff A, Addo D, Jacobs JA, Derington CG, Stulberg EL, Glynn PA, Modenesi B, Cohen JB, Bress AP. Out-of-Pocket Costs and Antihypertensive Medication Use Among Veterans: A Natural Experiment. J Am Heart Assoc. 2026 Apr 21; 15(8):e047792.
    View in: PubMed
    Score: 0.008
  15. Sanuade OA, Addo DK, Smith JD, Carroll AJ, Shimbo D, Talegawkar S, Tucker KL, Jacobs JA, Derington CG, Bress AP. The association of urinary sodium with incident apparent treatment resistant hypertension among African Americans: findings from the Jackson Heart Study. J Hum Hypertens. 2026 May; 40(5):405-412.
    View in: PubMed
    Score: 0.008
  16. Lu AD, Chavez C, Daugherty SL, Dhar P, Derington CG, Everhart R, Morse EF, Novins-Montague S, Trinkley KE, Waughtal JM, Zucker R, Carey E, Bull S, Peterson PN, Ho PM. Using artificially intelligent text messaging to improve health behaviors to reduce cardiovascular risk: study protocol for a pragmatic randomized control trial. Trials. 2026 Feb 20; 27(1).
    View in: PubMed
    Score: 0.008
  17. Sarwal A, Singh R, Wei G, Shen J, Nevers M, Hartsell SE, Derington CG, Takyi A, Chakravartula AR, Katkam N, Boucher RE, Drakos SG, Greene T, Beddhu S. Glycemic therapies and the risk of gastrointestinal adverse events in veterans with type 2 diabetes. Diabetes Obes Metab. 2025 Oct; 27(10):5865-5877.
    View in: PubMed
    Score: 0.008
  18. Shen J, Sarwal A, Singh R, Hartsell SE, Wei G, Nevers M, Christensen JC, Takyi A, Katkam N, Derington CG, Deshmukh VG, Boucher RE, Drakos SG, Greene T, Beddhu S. Comparative effectiveness of insulin glargine, glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors in veterans with type 2 diabetes. Diabetes Obes Metab. 2025 Apr; 27(4):2120-2130.
    View in: PubMed
    Score: 0.008
  19. Jacobs JA, Ayodele I, Bress AP, Sterling MR, Pandey A, Derington CG, Zheutlin AR, Shah KS, Greene SJ, Alhanti B, Blanco R, Fonarow GC. Social Determinants of Health and Disparities in Guideline-Directed Medical Therapy Optimization for Heart Failure. Circ Heart Fail. 2025 Jan; 18(1):e012357.
    View in: PubMed
    Score: 0.008
  20. Xu Y, Derington CG, Addo DK, He T, Jacobs JA, Mohanty AF, An J, Cushman WC, Ho PM, Bellows BK, Cohen JB, Bress AP. Trends in Initial Antihypertensive Medication Prescribing Among >2.8?Million Veterans Newly Diagnosed With Hypertension, 2000 to 2019. J Am Heart Assoc. 2024 10 15; 13(20):e036557.
    View in: PubMed
    Score: 0.007
  21. Jacobs JA, Rodgers A, Bellows BK, Hernandez I, Wang N, Derington CG, King JB, Zheutlin AR, Whelton PK, Egan BM, Cushman WC, Bress AP. Use and Cost Patterns of Antihypertensive Medications in the United States From 1996 to 2021. Hypertension. 2024 11; 81(11):2307-2317.
    View in: PubMed
    Score: 0.007
  22. Jacobs JA, Derington CG, Zheutlin AR, King JB, Cohen JB, Bucheit J, Kronish IM, Addo DK, Morisky DE, Greene TH, Bress AP. Association Between Self-Reported Medication Adherence and Therapeutic Inertia in Hypertension: A Secondary Analysis of SPRINT (Systolic Blood Pressure Intervention Trial). J Am Heart Assoc. 2024 02 06; 13(3):e031574.
    View in: PubMed
    Score: 0.007
  23. King JB, Berchie RO, Derington CG, Marcum ZA, Scharfstein DO, Greene TH, Herrick JS, Jacobs JA, Zheutlin AR, Bress AP, Cohen JB. New Users of Angiotensin II Receptor Blocker-Versus Angiotensin-Converting Enzyme Inhibitor-Based Antihypertensive Medication Regimens and Cardiovascular Disease Events: A Secondary Analysis of ACCORD-BP and SPRINT. J Am Heart Assoc. 2023 09 05; 12(17):e030311.
    View in: PubMed
    Score: 0.007
  24. King JB, Derington CG, Herrick JS, Jacobs JA, Zheutlin AR, Conroy MB, Cushman WC, Bress AP. Single-Pill Combination Product Availability of the Antihypertensive Regimens Used for Intensive Systolic Blood Pressure Treatment in the Systolic Blood Pressure Intervention Trial. Hypertension. 2023 08; 80(8):1749-1758.
    View in: PubMed
    Score: 0.007
  25. Jacobs JA, Addo DK, Zheutlin AR, Derington CG, Essien UR, Navar AM, Hernandez I, Lloyd-Jones DM, King JB, Rao S, Herrick JS, Bress AP, Pandey A. Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US: National Health and Nutrition Examination Surveys, 2013 to March 2020. JAMA Cardiol. 2023 05 01; 8(5):443-452.
    View in: PubMed
    Score: 0.007
  26. Ghazi L, Shen J, Ying J, Derington CG, Cohen JB, Marcum ZA, Herrick JS, King JB, Cheung AK, Williamson JD, Pajewski NM, Bryan N, Supiano M, Sonnen J, Weintraub WS, Greene TH, Bress AP. Identifying Patients for Intensive Blood Pressure Treatment Based on Cognitive Benefit: A Secondary Analysis of the SPRINT Randomized Clinical Trial. JAMA Netw Open. 2023 05 01; 6(5):e2314443.
    View in: PubMed
    Score: 0.007
  27. Zheutlin AR, Derington CG, Herrick JS, Rosenson RS, Poudel B, Safford MM, Brown TM, Jackson EA, Woodward M, Reading S, Orroth K, Exter J, Virani SS, Muntner P, Bress AP. Lipid-Lowering Therapy Use and Intensification Among United States Veterans Following Myocardial Infarction or Coronary Revascularization Between 2015 and 2019. Circ Cardiovasc Qual Outcomes. 2022 12; 15(12):e008861.
    View in: PubMed
    Score: 0.007
  28. Cohen JB, Marcum ZA, Zhang C, Derington CG, Greene TH, Ghazi L, Herrick JS, King JB, Cheung AK, Bryan N, Supiano MA, Sonnen JA, Weintraub WS, Scharfstein D, Williamson J, Pajewski NM, Bress AP. Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: A Secondary Analysis of Data From the Systolic Blood Pressure Intervention Trial (SPRINT). JAMA Netw Open. 2022 07 01; 5(7):e2220680.
    View in: PubMed
    Score: 0.006
  29. Weintraub WS, Bhatt DL, Zhang Z, Dolman S, Boden WE, Bress AP, King JB, Bellows BK, Tajeu GS, Derington CG, Johnson J, Andrade K, Steg PG, Miller M, Brinton EA, Jacobson TA, Tardif JC, Ballantyne CM, Kolm P. Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin Treatment. JAMA Netw Open. 2022 02 01; 5(2):e2148172.
    View in: PubMed
    Score: 0.006
  30. Zheutlin AR, Mondesir FL, Derington CG, King JB, Zhang C, Cohen JB, Berlowitz DR, Anstey DE, Cushman WC, Greene TH, Ogedegbe O, Bress AP. Analysis of Therapeutic Inertia and Race and Ethnicity in the Systolic Blood Pressure Intervention Trial: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2022 01 04; 5(1):e2143001.
    View in: PubMed
    Score: 0.006
  31. Marcum ZA, Cohen JB, Zhang C, Derington CG, Greene TH, Ghazi L, Herrick JS, King JB, Cheung AK, Bryan N, Supiano MA, Sonnen JA, Weintraub WS, Williamson J, Pajewski NM, Bress AP. Association of Antihypertensives That Stimulate vs Inhibit Types 2 and 4 Angiotensin II Receptors With Cognitive Impairment. JAMA Netw Open. 2022 01 04; 5(1):e2145319.
    View in: PubMed
    Score: 0.006
  32. Colvin CL, Poudel B, Bress AP, Derington CG, King JB, Wen Y, Chen L, Bittner V, Brown TM, Monda KL, Mues KE, Rosenson RS, Jackson EA, Muntner P, Colantonio LD. Race/ethnic and sex differences in the initiation of non-statin lipid-lowering medication following myocardial infarction. J Clin Lipidol. 2021 Sep-Oct; 15(5):665-673.
    View in: PubMed
    Score: 0.006
  33. Bress AP, Greene T, Derington CG, Shen J, Xu Y, Zhang Y, Ying J, Bellows BK, Cushman WC, Whelton PK, Pajewski NM, Reboussin D, Beddu S, Hess R, Herrick JS, Zhang Z, Kolm P, Yeh RW, Basu S, Weintraub WS, Moran AE. Patient Selection for Intensive Blood Pressure Management Based on Benefit and Adverse Events. J Am Coll Cardiol. 2021 04 27; 77(16):1977-1990.
    View in: PubMed
    Score: 0.006
  34. Owlia M, Dodson JA, King JB, Derington CG, Herrick JS, Sedlis SP, Crook J, DuVall SL, LaFleur J, Nelson R, Patterson OV, Shah RU, Bress AP. Angina Severity, Mortality, and Healthcare Utilization Among Veterans With Stable Angina. J Am Heart Assoc. 2019 08 06; 8(15):e012811.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)